HANetf ICAV Indxx Healthcare Innovation UCITS ETF Acc (WELP)
![](https://online.hl.co.uk/img/hl/layout/security-up-arrow.gif)
- Add to watchlist
- Create an alert
- This stock can be held in a
![](https://online.hl.co.uk/img/hl/layout/security-up-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
![](https://online.hl.co.uk/img/hl/layout/security-up-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
570.10p
572.40p
607.40p
London
569.30p
570.03p
481.50p
$17.57M
8.65p (1.54%) Previous:
8.65p
877
n/a
GBX
ETP Basics
Issuer: | HANetf ICAV |
---|---|
Structure: | ETF |
Replication method: | Stocks - Optimised |
Securities lending: | No |
Number of holdings: | 100 |
Size: | $17.6M |
Launch date: | 04 April 2019 |
Launch price: | $7.77 |
UCITS: | Yes |
Reporting status: | Yes |
Domicile: | Ireland |
Complex product: | Non-complex |
ISIN: | IE00BJQTJ848 |
Annual & interim reports
Before you invest, please make sure you read the documents below
Ready to invest?
Important Documents
There are no documents available for this stock.
OBJECTIVE
Index: | The Indxx Global NextGen Healthcare Index is designed to measure the performance of companies involved in the NextGen Healthcare sector, as defined by Indxx. |
---|---|
Aim: |
The Fund seeks to track the price and yield performance, before fees and expenses, of...
Read full aim for HANetf ICAV |
Leverage: | 100% |
Currency hedging: | No |
COSTS
Ongoing Charge (OCF/TER): | 0.59% |
---|---|
Management fee: | 0.59% |
Indicative spread: | 0.65% |
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
Performance
Not available for this stock.
Security | Weight |
---|---|
HIMS & HERS HEALTH INC | 1.80% |
SHOCKWAVE MEDICAL | 1.71% |
4D MOLECULAR THERAPEUTICS INC | 1.56% |
NATERA INC | 1.52% |
SAREPTA THERAPEUTICS | 1.43% |
EDWARDS LIFESCIENCES CORP | 1.28% |
TELIX PHARMACEUTICALS LTD | 1.27% |
VEEVA SYSTEMS | 1.24% |
BOSTON SCIENTIFIC CORPORATION | 1.23% |
INTUITIVE SURGICAL | 1.20% |
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.